Transcription Factor ASCL1 Targets SLC6A13 to Inhibit the Progression of Hepatocellular Carcinoma via the Glycine-Inflammasome Signaling. Biomol Biomed 2024, 24 (6), 1606–1619. https://doi.org/10.17305/bb.2024.10328.